A Case Report: Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus-2 Variant Causing Reinfection
0301 basic medicine
Immunology
Infectious disease (medical specialty)
Coronavirus Disease 2019 Research
FOS: Health sciences
Prediction of Peptide-MHC Binding Affinity
Microbiology
Gene
reinfection
Coronavirus Disease 2019
03 medical and health sciences
Biochemistry, Genetics and Molecular Biology
Virology
Health Sciences
Genetics
Disease
Molecular Biology
Biology
Internal medicine
Bangladesh
Corona Virus
Genome
SARS-CoV-2
FOS: Clinical medicine
Vaccination
COVID-19
Life Sciences
QR1-502
3. Good health
Coronavirus
Coronavirus disease 2019 (COVID-19)
Infectious Diseases
variant
Whole genome sequencing
FOS: Biological sciences
Medicine
DOI:
10.3389/fmicb.2021.792514
Publication Date:
2021-12-09T12:55:31Z
AUTHORS (11)
ABSTRACT
Background: The emergence of novel variants has been a great deal of international concern since the recently published data suggest that previous infections with SARS-CoV-2 may not protect an individual from new variants. We report a patient had two distinct episodes of COVID-19 with different variants of SARS-CoV-2.Methods: The nasopharyngeal samples collected from the two episodes were subjected to whole-genome sequencing and comparative genome analysis.Results: The first infection presented with mild symptoms, while the second infection presented with severe outcomes which occurred 74 days after the patient recovered from the first episode. He had elevated C-reactive protein, ferritin, and bilateral consolidation as a sign of acute infection. Genome analysis revealed that the strains from the first and second episodes belonged to two distinct Nexstrain clades 20B and 20I and Pangolin lineages B.1.1.25 and B.1.1.7, respectively. A total of 36 mutations were observed in the episode-2 strain when compared with the reference strain Wuhan-Hu-1. Among them, eight mutations were identified in the receptor-binding domain (RBD).Conclusion: Our findings concern whether the immunity acquired by natural infection or mass vaccination could confer adequate protection against the constantly evolving SARS-CoV-2. Therefore, continuous monitoring of genetic variations of SARS-CoV-2 strains is crucial for interventions such as vaccine and drug designs, treatment using monoclonal antibodies, and patient management.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....